David Batt
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Melanoma and MAPK Pathways
Papers in
-
- Melanoma and MAPK Pathways 4
- Protein Kinase Regulation and GTPase Signaling 2
- RNA and protein synthesis mechanisms 2
- Molecular Biology Techniques and Applications 2
- Oncology 8
- Polyomavirus and related diseases 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Thomas M. Roberts (4 shared papers)Francisca Vázquez (1 shared paper)Noriaki Nakamura (1 shared paper)Shivapriya Ramaswamy (1 shared paper)William R. Sellers (1 shared paper)Gordon Carmichael (5 shared papers)Naeem Yusuff (3 shared papers)Julian Downward (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Journal of Biological Chemistry (3 papers)Cancer Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Cell (2 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
David Batt
23 papers receiving 1.3k citations
David Batt's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 387
- Molecular Biology 894
- Cancer Research 147
- Pathology and Forensic Medicine 134
- Endocrinology, Diabetes and Metabolism 124
Countries citing papers authored by David Batt
This map shows the geographic impact of David Batt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Batt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Batt more than expected).
Fields of papers citing papers by David Batt
This network shows the impact of papers produced by David Batt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Batt. The network helps show where David Batt may publish in the future.
Co-authors
The 25 scholars most cited alongside David Batt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of G 1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway Hit paper breakdown → | 1999 | 506 |
| 2 | 2010 | 185 | |
| 3 | 2006 | 116 | |
| 4 | 1999 | 107 | |
| 5 | 2007 | 48 | |
| 6 | 2008 | 48 | |
| 7 | B-Raf kinase inhibitors for cancer treatment. | 2007 | 44 |
| 8 | 2006 | 43 | |
| 9 | 1998 | 43 | |
| 10 | 1994 | 41 | |
| 11 | 2007 | 36 | |
| 12 | 1999 | 24 | |
| 13 | 1994 | 24 | |
| 14 | 1999 | 17 | |
| 15 | 2005 | 14 | |
| 16 | 2010 | 11 | |
| 17 | 2008 | 10 | |
| 18 | 1994 | 5 | |
| 19 | 2015 | 4 | |
| 20 | 1995 | 4 |
About David Batt
David Batt is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Organic Chemistry and Genetics, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Polyomavirus and related diseases (3 papers), Cancer Mechanisms and Therapy (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), HER2/EGFR in Cancer Research (2 papers), RNA and protein synthesis mechanisms (2 papers), Molecular Biology Techniques and Applications (2 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Oncology (387 citations), Molecular Biology (894 citations), Cancer Research (147 citations), Pathology and Forensic Medicine (134 citations) and Endocrinology, Diabetes and Metabolism (124 citations). David Batt has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Thomas M. Roberts, Francisca Vázquez, Noriaki Nakamura, Shivapriya Ramaswamy, William R. Sellers, Gordon Carmichael, Naeem Yusuff, Julian Downward, Nanxin Li and Markus Warmuth. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Biological Chemistry, Cancer Research, Proceedings of the National Academy of Sciences and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.